About two months about Geron shocked and disappointed the stem cell community by dropping its stem cell program. The move was reportedly made for financial, not scientific reasons. Biotech companies have to be financially sound in order to help stem cell researchers turn science into cures and Geron’s leadership had to do what it thought […]
What does Geron’s departure mean for ACT? Some perspectives Read More »
A year from now will I still be conducted federally funded research on human ES cells? What about the hundreds of other professors in the U.S. and their thousands of employees? It is not unreasonable at this point to forecast a perfect storm in Fall 2012 that may kill elements of stem cell research that
The perfect storm in Fall 2012 that may kill ES cells research Read More »
Sometimes a top scientist makes news with a quote on research and that happened with Ian Wilmut recently on stem cells. Move away from research on human ES cells (hESC) in favor of very new and still largely unclear trans-differentiation technology? I say, no way. But, Bradley Fikes of the North County Times has reported
Ian Wilmut, Dolly’s dad, says dump hESC? What does this mean? Read More »
What is RNA-based iPS cell research? It was only six months ago that the stem cell field was aflutter over the report by the Rossi group that they could reprogram iPS cells with an astonishingly high efficiency using just RNAs. This completely non-genetic, high-efficiency approach seemed like a revolution for the iPS cell field. It
Is RNA-based iPS cell production a flash in the pan/tissue culture dish? Read More »
The BLT is reporting that the DC Circuit Appeals Court has sided with the government and has stayed Judge Lamberth’s injunction against ES cell research. Great news! And I’m happy to admit our grim predictions yesterday were wrong. The judges took the action in a “per curiam” judgement, meaning collectively. So we will not know
Appeals Court Stays Injunction, ES cell research remains legal Read More »